Natera, Inc.
NASDAQ:NTRA · NASDAQ Global Select
+$2.23 today
Vol 2.63M · Avg 1.41M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:NTRA · Revenue to Net Income
Key Ratios
Analysis
$2.5B of revenue converted into -$226.3M of net income for the selected period. Gross margin is 65.1% and net margin is -9.6%, showing how much revenue survives after costs and taxes. EPS is $-1.63, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B +35.9% | $1.7B +56.7% | $1.1B +32.0% | $820.2M +31.1% | $625.5M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $810.6M +20.3% | $673.8M +14.2% | $589.8M +29.3% | $456.3M +43.3% | $318.4M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.5B +46.2% | $1.0B +107.6% | $492.7M +35.4% | $364.0M +18.5% | $307.1M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 64.8% +4.6pp | 60.3% +14.8pp | 45.5% +1.1pp | 44.4% -4.7pp | 49.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $624.1M +54.4% | $404.1M +26.0% | $320.7M +1.3% | $316.4M +19.8% | $264.2M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.2B +39.9% | $841.3M +36.1% | $618.3M +5.0% | $588.6M +15.2% | $511.0M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.8B +45.0% | $1.2B +32.6% | $939.0M +3.8% | $905.0M +16.7% | $775.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $43.5M +40.4% | $31.0M -19.8% | $38.6M +26.7% | $30.5M +170.8% | $11.3M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$220.5M -48.9% | -$148.1M +61.4% | -$383.3M +24.4% | -$507.0M -12.3% | -$451.5M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -9.6% -0.8pp | -8.7% +26.7pp | -35.4% +26.4pp | -61.8% +10.4pp | -72.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$309.9M -39.4% | -$222.3M +50.2% | -$446.2M +17.5% | -$541.0M -15.6% | -$468.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -13.4% -0.3pp | -13.1% +28.1pp | -41.2% +24.7pp | -66.0% +8.9pp | -74.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $45.9M +6.1% | $43.2M +77.6% | $24.4M +588.3% | $3.5M -34.3% | $5.4M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $4.1M -61.9% | $10.7M -15.5% | $12.6M +35.6% | $9.3M +12.2% | $8.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $41.8M +28.4% | $32.6M +178.0% | $11.7M +302.6% | -$5.8M -97.7% | -$2.9M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$268.1M -41.3% | -$189.7M +56.3% | -$434.5M +20.5% | -$546.8M -16.1% | -$471.1M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -11.6% -0.4pp | -11.2% +29.0pp | -40.1% +26.5pp | -66.7% +8.6pp | -75.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$59.9M -8722.9% | $695.0K +156.5% | $271.0K -72.3% | $978.0K +58.3% | $618.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$208.2M -9.3% | -$190.4M +56.2% | -$434.8M +20.6% | -$547.8M -16.1% | -$471.7M | $4.9B | $4.8B | $4.7B |
| Net Margin | -9.0% +2.2pp | -11.2% +28.9pp | -40.2% +26.6pp | -66.8% +8.6pp | -75.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$2 +0.7% | -$2 +59.5% | -$4 +32.1% | -$6 -6.9% | -$5 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$2 +0.7% | -$2 +59.5% | -$4 +32.1% | -$6 -6.9% | -$5 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $136.7M +9.6% | $124.7M +8.5% | $115.0M +16.9% | $98.4M +8.7% | $90.6M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $136.7M +9.6% | $124.7M +8.5% | $115.0M +16.9% | $98.4M +8.7% | $90.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Teva Pharmaceutical Industries Limited
NYSE:TEVA
$36.61B
IQVIA Holdings Inc.
NYSE:IQV
$28.05B
DexCom, Inc.
NASDAQ:DXCM
$27.83B
Koninklijke Philips N.V.
NYSE:PHG
$26.02B
Illumina, Inc.
NASDAQ:ILMN
$24.53B
Waters Corporation
NYSE:WAT
$23.26B
Mettler-Toledo International Inc.
NYSE:MTD
$23.17B
BioNTech SE
NASDAQ:BNTX
$23.08B
Quest Diagnostics Incorporated
NYSE:DGX
$21.44B
STERIS plc
NYSE:STE
$19.70B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NTRA generate?
Natera, Inc. (NTRA) reported $2.31B of revenue in fiscal 2025.
Is NTRA profitable?
Natera, Inc. (NTRA) reported -$208,160,000.00 of net income, with a net margin of -9.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.